Bharat Biotech on Sunday said it has started clinical trials of the Tuberculosis vaccine MTBVAC on adults in India. This is the first vaccine against Tuberculosis derived from a human source by the Spanish biopharmaceutical company Biofabri, Bharat Biotech said in a press release. Notably, WHO says two deaths occur every three minutes from tuberculosis in India.